Filings
Finds words inside filing documents. Searching InMed Pharmaceuticals Inc.'s filings · 76 documents indexed.
9 documents · 81 matches
-
INM InMed Pharmaceuticals Inc. 10-K 2026-09-09
Item 1A. Risk Factors
going concern may materially and adversely affect the price of our Common Shares, and it may be more difficult for us to obtain15 matches in this document -
INM InMed Pharmaceuticals Inc. 10-K 2025-09-23
Item 1A. Risk Factors
going concern may materially and adversely affect the price of our Common Shares, and it may be more difficult for us to obtain16 matches in this document -
INM InMed Pharmaceuticals Inc. 10-K 2022-09-23
Item 1A. Risk Factors
going concern may materially and adversely affect the price of our common shares, and it may be more difficult for us to obtain13 matches in this document -
INM InMed Pharmaceuticals Inc. 10-Q 2026-11-03
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise7 matches in this document -
INM InMed Pharmaceuticals Inc. 10-Q 2026-05-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise8 matches in this document -
INM InMed Pharmaceuticals Inc. 10-Q 2026-02-11
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise7 matches in this document -
INM InMed Pharmaceuticals Inc. 10-Q 2025-11-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise7 matches in this document -
INM InMed Pharmaceuticals Inc. 10-Q 2025-05-12
Item 1 · Note 1. Corporate Information and Continuing Operations
going concern considerations in accordance with Subtopic 205-40, management has determined that the Company’s liquidity condition raises substantial7 matches in this document -
INM InMed Pharmaceuticals Inc. 8-K 2025-06-13
Item 4.01. Changes in Registrant’s Certifying Accountant
inclusion of an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern.1 match in this document
Page 1 of 1 · 9 documents